Since its establishment in 2009, Zhenjuntang Biotechnology Co. Ltd. has invested more than NT$2.2 billion across the Taiwan Strait to manage 158 operation centers in 21 of China’s provinces. The Taipei-based company aims to highlight the alleged benefits of stout camphor fungus, also called “niu zhang zhi” in Chinese, a promising medicinal mushroom from Taiwan, in the fight against cancer. Read the full story in the China Post.
- Chugai’s advanced non-small cell lung cancer drug approved in Taiwan
- Taiwan’s Amaran Biotech announces partnership with Stellar Biotech for supply of KLH vaccine